Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
1.
Front Pharmacol ; 15: 1428925, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39411066

RESUMEN

Given that there is currently no clinically approved drug or vaccine for parainfluenza 3 (PIV3), we applied a drug repurposing method based on disease similarity and chemical similarity to screen 2,585 clinically approved chemical drugs using PIV3 potential drugs BCX-2798 and zanamivir as our controls. Twelve candidate drugs were obtained after being screened with good disease similarity and chemical similarity (S > 0.50, T > 0.56). When docking them with the PIV3 target protein, hemagglutinin-neuraminidase (HN), only oseltamivir was docked with a better score than BCX-2798, which indicates that oseltamivir has an inhibitory effect on PIV3. After the distance ( Z d c ) between the drug target of 14 drugs and the PIV3 disease target was measured by the network proximity method based on the PIV3 disease module, it was found that the Z d c values of amikacin, oseltamivir, ribavirin, and streptomycin were less than those of the control. Thus, oseltamivir is the best potential drug because it met all the above screening requirements. Additionally, to explore whether oseltamivir binds to HN stably, molecular dynamics simulation of the binding of oseltamivir to HN was carried out, and the results showed that the RMSD value of the complex tended to be stable within 100 ns, and the binding free energy of the complex was low (-10.60 kcal/mol). It was proved that oseltamivir screened by our drug repurposing method had the potential feasibility of treating PIV3.

2.
Expert Opin Drug Discov ; 19(9): 1043-1069, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39004919

RESUMEN

INTRODUCTION: Small molecules often bind to multiple targets, a behavior termed polypharmacology. Anticipating polypharmacology is essential for drug discovery since unknown off-targets can modulate safety and efficacy - profoundly affecting drug discovery success. Unfortunately, experimental methods to assess selectivity present significant limitations and drugs still fail in the clinic due to unanticipated off-targets. Computational methods are a cost-effective, complementary approach to predict polypharmacology. AREAS COVERED: This review aims to provide a comprehensive overview of the state of polypharmacology prediction and discuss its strengths and limitations, covering both classical cheminformatics methods and bioinformatic approaches. The authors review available data sources, paying close attention to their different coverage. The authors then discuss major algorithms grouped by the types of data that they exploit using selected examples. EXPERT OPINION: Polypharmacology prediction has made impressive progress over the last decades and contributed to identify many off-targets. However, data incompleteness currently limits most approaches to comprehensively predict selectivity. Moreover, our limited agreement on model assessment challenges the identification of the best algorithms - which at present show modest performance in prospective real-world applications. Despite these limitations, the exponential increase of multidisciplinary Big Data and AI hold much potential to better polypharmacology prediction and de-risk drug discovery.


Asunto(s)
Algoritmos , Biología Computacional , Descubrimiento de Drogas , Polifarmacología , Humanos , Descubrimiento de Drogas/métodos , Biología Computacional/métodos , Quimioinformática/métodos , Animales
3.
Plants (Basel) ; 13(2)2024 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-38256769

RESUMEN

Ants patrol foliage and exert a strong selective pressure on herbivorous insects, being their primary predators. As ants are chemically oriented, some organisms that interact with them (myrmecophiles) use chemical strategies mediated by their cuticular hydrocarbons (CHCs) to deal with ants. Thus, a better understanding of the ecology and evolution of the mutualistic interactions between myrmecophiles and ants depends on the accurate recognition of these chemical strategies. Few studies have examined whether treehoppers may use an additional strategy called chemical camouflage to reduce ant aggression, and none considered highly polyphagous pest insects. We analyzed whether the chemical similarity of the CHC profiles of three host plants from three plant families (Fabaceae, Malvaceae, and Moraceae) and the facultative myrmecophilous honeydew-producing treehopper Aetalion reticulatum (Hemiptera: Aetalionidae), a pest of citrus plants, may play a role as a proximate mechanism serving as a protection against ant attacks on plants. We found a high similarity (>80%) between the CHCs of the treehoppers and two of their host plants. The treehoppers acquire CHCs through their diet, and the chemical similarity varies according to host plant. Chemical camouflage on host plants plays a role in the interaction of treehoppers with their ant mutualistic partners.

4.
Drug Dev Ind Pharm ; 50(2): 150-162, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38194223

RESUMEN

OBJECTIVE: This study aims to investigate the quality consistency between traditional decoction (TD) of Amomum villosum and its dispensing granule decoction (DGD). Fifteen batches of TD and nine batches of dispensing granules (manufactured by A, B, and C) were prepared and evaluated for their consistency. METHODS: Firstly, The chemical similarity of TD and DGD was examined using GC and HPLC, coupled with hierarchical cluster analysis (HCA), criteria importance though intercrieria correlation(CRITIC) weighting method, and principal component analysis (PCA). Secondly, the gastrointestinal motility experiments in mice, along with the CRITIC weighting method, were employed to assess the bioequivalence of TD and DGD of Amomum villosum. Finally, the entropy weight technique-gray relative analysis(GRA) method was used to compare the quality of Amomum villosum decoctions. RESULTS: ①The CRITIC weighting method indicated significantly higher scores for TD than DGD (p < 0.01). HCA and PCA results demonstrated a clear distinction between TD and DGD. ②Gastrointestinal motility test results revealed no significant difference between TD and DGD in other indicators (p > 0.05).③Gray relative analysis results showed that the relative correlation of TD was more significant than that of DGD. CONCLUSION: The chemical composition of DGD and TD differed. The biological activity of DGD-A/B was consistent with that of TD, while the difference between DGD-C and TD was significant. A comprehensive evaluation showed that TD exhibited better quality than DGD. DGD manufacturers should optimize the preparation process to enhance product quality.


Asunto(s)
Amomum , Medicamentos Herbarios Chinos , Animales , Ratones , Medicamentos Herbarios Chinos/química , Amomum/química , Equivalencia Terapéutica , Cromatografía Líquida de Alta Presión/métodos , Análisis de Componente Principal
5.
Patterns (N Y) ; 4(12): 100865, 2023 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-38106612

RESUMEN

Chemical similarity searches are a widely used family of in silico methods for identifying pharmaceutical leads. These methods historically relied on structure-based comparisons to compute similarity. Here, we use a chemical language model to create a vector-based chemical search. We extend previous implementations by creating a prompt engineering strategy that utilizes two different chemical string representation algorithms: one for the query and the other for the database. We explore this method by reviewing search results from nine queries with diverse targets. We find that the method identifies molecules with similar patent-derived functionality to the query, as determined by our validated LLM-assisted patent summarization pipeline. Further, many of these functionally similar molecules have different structures and scaffolds from the query, making them unlikely to be found with traditional chemical similarity searches. This method may serve as a new tool for the discovery of novel molecular structural classes that achieve target functionality.

6.
SAR QSAR Environ Res ; : 1-19, 2023 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-37982180

RESUMEN

A novel method is introduced for estimating the degree of interactions occurring between two different compounds in a binary mixture resulting in deviations from ideality as predicted by Raoult's law. Metrics of chemical similarity between binary mixture components were used as descriptors and correlated with the Root-Mean Square Error (RMSE) associated with Raoult's law calculations of total vapour pressure prediction, including Abraham descriptors, sigma moments, and several chemical properties. The best correlation was for a quantitative structure-activity relationship (QSAR) equation using differences in Abraham parameters as descriptors (r2 = 0.7585), followed by a QSAR using differences in COSMO-RS sigma moment descriptors (r2 = 0.7461), and third by a QSAR using differences in the chemical properties of log KAW, melting point, and molecular weight as descriptors (r2 = 0.6878). Of these chemical properties, Δlog KAW had the strongest correlation with deviation from Raoult's law (RMSE) and this property alone resulted in an r2 of 0.6630. These correlations are useful for assessing the expected deviation in Raoult's law estimations of vapour pressures, a key property for estimating inhalation exposure.

7.
Protein Sci ; 32(4): e4594, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-36776141

RESUMEN

We describe the Predicting Protein-Compound Interactions (PrePCI) database which comprises over 5 billion predicted interactions between 6.8 million chemical compounds and 19,797 human proteins. PrePCI relies on a proteome-wide database of structural models based on both traditional modeling techniques and the AlphaFold Protein Structure Database. Sequence- and structural similarity-based metrics are established between template proteins, T, in the Protein Data Bank that bind compounds, C, and query proteins in the model database, Q. When the metrics exceed threshold values, it is assumed that C also binds to Q with a likelihood ratio (LR) derived from machine learning. If the relationship is based on structural similarity, the LR is based on a scoring function that measures the extent to which C is compatible with the binding site of Q as described in the LT-scanner algorithm. For every predicted complex derived in this way, chemical similarity based on the Tanimoto coefficient identifies other small molecules that may bind to Q. An overall LR for the binding of C to Q is obtained from Naive Bayesian statistics. The PrePCI database can be queried by entering a UniProt ID or gene name for a protein to obtain a list of compounds predicted to bind to it along with associated LRs. Alternatively, entering an identifier for the compound outputs a list of proteins it is predicted to bind. Specific applications of the database to lead discovery, elucidation of drug mechanism of action, and biological function annotation are described.


Asunto(s)
Bases de Datos de Compuestos Químicos , Proteínas , Humanos , Teorema de Bayes , Proteínas/química , Algoritmos , Bases de Datos de Proteínas
8.
J Cheminform ; 14(1): 87, 2022 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-36578091

RESUMEN

This article demonstrates how to create Chemical Space Networks (CSNs) using a Python RDKit and NetworkX workflow. CSNs are a type of network visualization that depict compounds as nodes connected by edges, defined as a pairwise relationship such as a 2D fingerprint similarity value. A step by step approach is presented for creating two different CSNs in this manuscript, one based on RDKit 2D fingerprint Tanimoto similarity values, and another based on maximum common substructure similarity values. Several different CSN visualization features are included in the tutorial including methods to represent nodes with color based on bioactivity attribute value, edges with different line styles based on similarity value, as well as replacing the circle nodes with 2D structure depictions. Finally, some common network property and analysis calculations are presented including the clustering coefficient, degree assortativity, and modularity. All code is provided in the form of Jupyter Notebooks and is available on GitHub with a permissive BSD-3 open-source license: https://github.com/vfscalfani/CSN_tutorial.

9.
Brief Bioinform ; 23(3)2022 05 13.
Artículo en Inglés | MEDLINE | ID: mdl-35511108

RESUMEN

MOTIVATION: Interaction between transcription factor (TF) and its target genes establishes the knowledge foundation for biological researches in transcriptional regulation, the number of which is, however, still limited by biological techniques. Existing computational methods relevant to the prediction of TF-target interactions are mostly proposed for predicting binding sites, rather than directly predicting the interactions. To this end, we propose here a graph attention-based autoencoder model to predict TF-target gene interactions using the information of the known TF-target gene interaction network combined with two sequential and chemical gene characters, considering that the unobserved interactions between transcription factors and target genes can be predicted by learning the pattern of the known ones. To the best of our knowledge, the proposed model is the first attempt to solve this problem by learning patterns from the known TF-target gene interaction network. RESULTS: In this paper, we formulate the prediction task of TF-target gene interactions as a link prediction problem on a complex knowledge graph and propose a deep learning model called GraphTGI, which is composed of a graph attention-based encoder and a bilinear decoder. We evaluated the prediction performance of the proposed method on a real dataset, and the experimental results show that the proposed model yields outstanding performance with an average AUC value of 0.8864 +/- 0.0057 in the 5-fold cross-validation. It is anticipated that the GraphTGI model can effectively and efficiently predict TF-target gene interactions on a large scale. AVAILABILITY: Python code and the datasets used in our studies are made available at https://github.com/YanghanWu/GraphTGI.


Asunto(s)
Redes Neurales de la Computación
10.
J Comput Chem ; 43(15): 1042-1052, 2022 06 05.
Artículo en Inglés | MEDLINE | ID: mdl-35403727

RESUMEN

Screening and prioritization of chemicals is essential to ensure that available evaluation capacity is invested in those substances that are of highest concern. We, therefore, recently developed structural similarity models that evaluate the structural similarity of substances with unknown properties to known Substances of Very High Concern (SVHC), which could be an indication of comparable effects. In the current study the performance of these models is improved by (1) separating known SVHCs in more specific subgroups, (2) (re-)optimizing similarity models for the various SVHC-subgroups, and (3) improving interpretability of the predicted outcomes by providing a confidence score. The improvements are directly incorporated in a freely accessible web-based tool, named the ZZS similarity tool: https://rvszoeksysteem.rivm.nl/ZzsSimilarityTool. Accordingly, this tool can be used by risk assessors, academia and industrial partners to screen and prioritize chemicals for further action and evaluation within varying frameworks, and could support the identification of tomorrow's substances of concern.

11.
J Pharm Biomed Anal ; 213: 114708, 2022 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-35272127

RESUMEN

Dispensing granules of Chinese herbal medicines are gaining more and more recognition. Despite this, how to evaluate the quality consistency between traditional decoction and its corresponding dispensing granules is a challenging task. In this work, we attempted to propose a comprehensive strategy through in vitro and in vivo comparisons to overcome this challenge, taking Gardeniae Fructus as a typical case. On one hand, HPLC fingerprinting and multi-component quantification were performed to evaluate chemical similarity. On the other hand, pharmacokinetic profiling was conducted to estimate bioequivalence in terms of concentration-time curve and key pharmacokinetic parameters. The in vitro and in vivo comparison results demonstrated that there were no significant differences between these two dosage forms. This proposed strategy is applicable not only for quality consistency evaluation between dispensing granules and traditional decoction but also for broader application scenarios.


Asunto(s)
Medicamentos Herbarios Chinos , Gardenia , Cromatografía Líquida de Alta Presión , Frutas , Equivalencia Terapéutica
12.
Environ Sci Technol ; 56(3): 2054-2064, 2022 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-34995441

RESUMEN

Solute descriptors have been widely used to model chemical transfer processes through poly-parameter linear free energy relationships (pp-LFERs); however, there are still substantial difficulties in obtaining these descriptors accurately and quickly for new organic chemicals. In this research, models (PaDEL-DNN) that require only SMILES of chemicals were built to satisfactorily estimate pp-LFER descriptors using deep neural networks (DNN) and the PaDEL chemical representation. The PaDEL-DNN-estimated pp-LFER descriptors demonstrated good performance in modeling storage-lipid/water partitioning coefficient (log Kstorage-lipid/water), bioconcentration factor (BCF), aqueous solubility (ESOL), and hydration free energy (freesolve). Then, assuming that the accuracy in the estimated values of widely available properties, e.g., logP (octanol-water partition coefficient), can calibrate estimates for less available but related properties, we proposed logP as a surrogate metric for evaluating the overall accuracy of the estimated pp-LFER descriptors. When using the pp-LFER descriptors to model log Kstorage-lipid/water, BCF, ESOL, and freesolve, we achieved around 0.1 log unit lower errors for chemicals whose estimated pp-LFER descriptors were deemed "accurate" by the surrogate metric. The interpretation of the PaDEL-DNN models revealed that, for a given test chemical, having several (around 5) "similar" chemicals in the training data set was crucial for accurate estimation while the remaining less similar training chemicals provided reasonable baseline estimates. Lastly, pp-LFER descriptors for over 2800 persistent, bioaccumulative, and toxic chemicals were reasonably estimated by combining PaDEL-DNN with the surrogate metric. Overall, the PaDEL-DNN/surrogate metric and newly estimated descriptors will greatly benefit chemical transfer modeling.


Asunto(s)
Compuestos Orgánicos , Agua , Fenómenos Químicos , Redes Neurales de la Computación , Octanoles , Compuestos Orgánicos/química , Agua/química
13.
J Math Chem ; 60(1): 239-254, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34840396

RESUMEN

In this work, a new version of Rényi's divergence is presented. The expression obtained is used as a tool to identify molecules that could share some chemical or structural properties, and a data basis set of 1641 molecules is used in this study. Our results suggest that this new form of Rényi divergence could be a useful tool that will eventually permit complementary studies in which the main goal is to obtain molecules with similar properties.

14.
Artículo en Inglés | MEDLINE | ID: mdl-38125869

RESUMEN

Off-target binding is one of the primary causes of toxic side effects of drugs in clinical development, resulting in failures of clinical trials. While off-target drug binding is a known phenomenon, experimental identification of the undesired protein binders can be prohibitively expensive due to the large pool of possible biological targets. Here, we propose a new strategy combining chemical similarity principle and deep learning to enable proteome-wide mapping of compound-protein interactions. We have developed a pipeline to identify the targets of bioactive molecules by matching them with chemically similar annotated "bait" compounds and ranking them with deep learning. We have constructed a user-friendly web server for drug-target identification based on chemical similarity (DRIFT) to perform searches across annotated bioactive compound datasets, thus enabling high-throughput, multi-ligand target identification, as well as chemical fragmentation of target-binding moieties.

15.
Front Chem ; 9: 736509, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34751244

RESUMEN

Clinical trials of novel therapeutics for Alzheimer's Disease (AD) have consumed a significant amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA), or Worldwide for another indication is a more rapid and less expensive option. Therefore, we apply the scaffold searching approach based on known amyloid-beta (Aß) inhibitor tramiprosate to screen the DrugCentral database (n = 4,642) of clinically tested drugs. As a result, menadione bisulfite and camphotamide substances with protrombogenic and neurostimulation/cardioprotection effects were identified as promising Aß inhibitors with an improved binding affinity (ΔGbind) and blood-brain barrier permeation (logBB). Finally, the data was also confirmed by molecular dynamics simulations using implicit solvation, in particular as Molecular Mechanics Generalized Born Surface Area (MM-GBSA) model. Overall, the proposed in silico pipeline can be implemented through the early stage rational drug design to nominate some lead candidates for AD, which will be further validated in vitro and in vivo, and, finally, in a clinical trial.

16.
Brief Bioinform ; 22(3)2021 05 20.
Artículo en Inglés | MEDLINE | ID: mdl-32597467

RESUMEN

Drug similarity studies are driven by the hypothesis that similar drugs should display similar therapeutic actions and thus can potentially treat a similar constellation of diseases. Drug-drug similarity has been derived by variety of direct and indirect sources of evidence and frequently shown high predictive power in discovering validated repositioning candidates as well as other in-silico drug development applications. Yet, existing resources either have limited coverage or rely on an individual source of evidence, overlooking the wealth and diversity of drug-related data sources. Hence, there has been an unmet need for a comprehensive resource integrating diverse drug-related information to derive multi-evidenced drug-drug similarities. We addressed this resource gap by compiling heterogenous information for an exhaustive set of small-molecule drugs (total of 10 367 in the current version) and systematically integrated multiple sources of evidence to derive a multi-modal drug-drug similarity network. The resulting database, 'DrugSimDB' currently includes 238 635 drug pairs with significant aggregated similarity, complemented with an interactive user-friendly web interface (http://vafaeelab.com/drugSimDB.html), which not only enables database ease of access, search, filtration and export, but also provides a variety of complementary information on queried drugs and interactions. The integration approach can flexibly incorporate further drug information into the similarity network, providing an easily extendable platform. The database compilation and construction source-code has been well-documented and semi-automated for any-time upgrade to account for new drugs and up-to-date drug information.


Asunto(s)
Algoritmos , Simulación por Computador , Bases de Datos Farmacéuticas , Reposicionamiento de Medicamentos , Preparaciones Farmacéuticas , Programas Informáticos , Humanos
17.
J Biomol Struct Dyn ; 39(16): 6031-6043, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-32696721

RESUMEN

Malaria is a protozoan infection transmitted by the bite of the infected female mosquito belonging to the genus Anopheles spp., which causes more than 445 million annual deaths worldwide. Available drugs have serious adverse effects (e.g. blurred vision, hypotension and headache) and species-dependent efficacy. An alternative to overcome these problems involve the use of molecules with affinity to the Anopheles gambiae mosquito odor receptors, minimizing the reinfection process as well as reducing the problems related to pharmacological therapy. The vector control can interrupt the epidemiological cycle and, therefore, control the malaria incidence. In the olfactory pathway, odorant binding protein 1 acts on the first level of odor recognition on malarial vector and thus can be used to modulate mosquito behavior and development of new attracts or repellents. Thus, this study applied ligand-based (2D-chemical similarity) and structure-based (docking and molecular dynamics) computational approaches to prioritize potential olfactory modulators on natural products catalogs at ZINC15 database (n = 98,379). Hierarchical virtual screening prioritized a potential olfactory modulator (Z8217) against Anopheles gambiae odorant binding protein 1 (AgOBP1). Next, it was submitted to molecular dynamics routine to identify structural requirements and the interactions profile required for binding-site affinity. This promising natural compound can interact like experimental ligand and will be used in repellency assay to confirm its sensorial behavior.Communicated by Ramaswamy H. Sarma.


Asunto(s)
Anopheles , Receptores Odorantes , Animales , Anopheles/metabolismo , Proteínas Portadoras , Femenino , Simulación de Dinámica Molecular , Mosquitos Vectores , Odorantes , Receptores Odorantes/genética , Receptores Odorantes/metabolismo
18.
Regul Toxicol Pharmacol ; 119: 104834, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33227364

RESUMEN

Due to the large amount of chemical substances on the market, fast and reproducible screening is essential to prioritize chemicals for further evaluation according to highest concern. We here evaluate the performance of structural similarity models that are developed to identify potential substances of very high concern (SVHC) based on structural similarity to known SVHCs. These models were developed following a systematic analysis of the performance of 112 different similarity measures for varying SVHC-subgroups. The final models consist of the best combinations of fingerprint, similarity coefficient and similarity threshold, and suggested a high predictive performance (≥80%) on an internal dataset consisting of SVHC and non-SVHC substances. However, the application performance on an external dataset was not evaluated. Here, we evaluated the application performance of the developed similarity models with a 'pseudo-external assessment' on a set of substances (n = 60-100 for the varying SVHC-subgroups) that were putatively assessed as SVHC or non-SVHC based upon consensus scoring using expert elicitations (n = 30 experts). Expert scores were direct evaluations based on structural similarity to the most similar SVHCs according to the similarity models, and did not consider an extensive evaluation of available data. The use of expert opinions is particularly suitable as this is exactly the intended purpose of the chemical similarity models: a quick, reproducible and automated screening tool that mimics the expert judgement that is frequently applied in various screening applications. In addition, model predictions were analyzed via qualitative approaches and discussed via specific examples, to identify the model's strengths and limitations. The results indicate a good statistical performance for carcinogenic, mutagenic or reprotoxic (CMR) and endocrine disrupting (ED) substances, whereas a moderate performance was observed for (very) persistent, (very) bioaccumulative and toxic (PBT/vPvB) substances when compared to expert opinions. For the PBT/vPvB model, particularly false positive substances were identified, indicating the necessity of outcome interpretation. The developed similarity models are made available as a freely-accessible online tool. In general, the structural similarity models showed great potential for screening and prioritization purposes. The models proved to be effective in identifying groups of substances of potential concern, and could be used to identify follow-up directions for substances of potential concern.


Asunto(s)
Sustancias Peligrosas/química , Sustancias Peligrosas/toxicidad , Modelos Teóricos , Alternativas a las Pruebas en Animales , Compuestos de Bencidrilo/química , Compuestos de Bencidrilo/toxicidad , Carcinógenos/química , Carcinógenos/toxicidad , Dieta , Disruptores Endocrinos/química , Disruptores Endocrinos/toxicidad , Estructura Molecular , Mutágenos/química , Mutágenos/toxicidad , Fenoles/química , Fenoles/toxicidad , Medición de Riesgo , Relación Estructura-Actividad , Triazoles/química , Triazoles/toxicidad
19.
ChemMedChem ; 14(23): 1995-2004, 2019 12 04.
Artículo en Inglés | MEDLINE | ID: mdl-31670463

RESUMEN

Enoyl-acyl carrier protein reductase (FabI) is the limiting step to complete the elongation cycle in type II fatty acid synthase (FAS) systems and is a relevant target for antibacterial drugs. E. coli FabI has been employed as a model to develop new inhibitors against FAS, especially triclosan and diphenyl ether derivatives. Chemical similarity models (CSM) were used to understand which features were relevant for FabI inhibition. Exhaustive screening of different CSM parameter combinations featured chemical groups, such as the hydroxy group, as relevant to distinguish between active/decoy compounds. Those chemical features can interact with the catalytic Tyr156. Further molecular dynamics simulation of FabI revealed the ionization state as a relevant for ligand stability. Also, our models point the balance between potency and the occupancy of the hydrophobic pocket. This work discusses the strengths and weak points of each technique, highlighting the importance of complementarity among approaches to elucidate EcFabI inhibitor's binding mode and offers insights for future drug discovery.


Asunto(s)
Antibacterianos/síntesis química , Enoil-ACP Reductasa (NADH)/antagonistas & inhibidores , Inhibidores Enzimáticos/síntesis química , Proteínas de Escherichia coli/antagonistas & inhibidores , Triclosán/análogos & derivados , Triclosán/síntesis química , Secuencia de Aminoácidos , Antibacterianos/farmacología , Sitios de Unión , Evaluación Preclínica de Medicamentos , Enoil-ACP Reductasa (NADH)/metabolismo , Inhibidores Enzimáticos/farmacología , Escherichia coli/química , Proteínas de Escherichia coli/metabolismo , Acido Graso Sintasa Tipo II/antagonistas & inhibidores , Acido Graso Sintasa Tipo II/metabolismo , Humanos , Ligandos , Modelos Moleculares , Unión Proteica , Conformación Proteica , Relación Estructura-Actividad , Triclosán/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...